The major birch pollen allergen, Bet v 1, shows ribonuclease activity

被引:1
|
作者
Bufe, A
Spangfort, MD
Kahlert, H
Schlaak, M
Becker, WM
机构
[1] ALK RES,HORSHOLM,DENMARK
[2] ALLERGOPHARMA,RES LABS,D-21465 REINBEK,GERMANY
关键词
allergen; Betula (pollen); pathogenesis-related protein; pollen; ribonuclease;
D O I
暂无
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The major birch (Betula alba L.) pollen allergen, Bet v 1, has been shown to be homologous to pathogenesis-related proteins in a number of plants. Recently, it was demonstrated that a ginseng protein with high homology to an intracellular pathogenesis-related protein of parsley and to Bet v 1 is a ribonuclease (RNase). Birch pollen extract was separated in an RNase activity gel. Four major RNase bands were excised from the gel, reseparated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and identified by Western blotting with a specific Bet v 1 monoclonal antibody and patient's serum. Thus the monomer and the dimer of Bet v 1 showed RNase activity. Purified recombinant Bet v 1 was shown to degrade plant RNA. The RNase activity of recombinant Bet v 1 was 180 units . mg(-1).
引用
收藏
页码:413 / 415
页数:3
相关论文
共 50 条
  • [1] Bioavailability of the major birch pollen allergen Bet v 1
    Ochs, S
    Wallmuth, A
    Kasche, A
    Weichenmeier, I
    Traidl-Hoffmann, C
    Huss-Marp, J
    Krämer, U
    Link, E
    Gebauer, G
    Schober, W
    Behrendt, H
    Buters, JTM
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 134 - 134
  • [2] The History and Science of the Major Birch Pollen Allergen Bet v 1
    Breiteneder, Heimo
    Kraft, Dietrich
    [J]. BIOMOLECULES, 2023, 13 (07)
  • [3] Ligand Recognition of the Major Birch Pollen Allergen Bet v 1 is Isoform Dependent
    von Loetzen, Christian Seutter
    Jacob, Thessa
    Hartl-Spiegelhauer, Olivia
    Vogel, Lothar
    Schiller, Dirk
    Spoerlein-Guettler, Cornelia
    Schobert, Rainer
    Vieths, Stefan
    Hartl, Maximilian Johannes
    Roesch, Paul
    [J]. PLOS ONE, 2015, 10 (06):
  • [4] Dynamics Rationalize Proteolytic Susceptibility of the Major Birch Pollen Allergen Bet v 1
    Kamenik, Anna S.
    Hofer, Florian
    Handle, Philip H.
    Liedl, Klaus R.
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [5] Secret of the major birch pollen allergen Bet v 1: identification of the physiological ligand
    Seutter von Loetzen, Christian
    Hoffmann, Thomas
    Hartl, Maximilian J.
    Schweimer, Kristian
    Schwab, Wilfried
    Roesch, Paul
    Hartl-Spiegelhauer, Olivia
    [J]. BIOCHEMICAL JOURNAL, 2014, 457 : 379 - 390
  • [6] Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1
    Vrtala, S
    Hirtenlehner, K
    Susani, M
    Akdis, M
    Kussebi, F
    Akdis, CA
    Blaser, K
    Hufnagl, P
    Binder, BR
    Politou, A
    Pastore, A
    Vangelista, L
    Sperr, WR
    Semper, H
    Valent, P
    Ebner, C
    Kraft, D
    Valenta, R
    [J]. FASEB JOURNAL, 2001, 15 (09): : 2045 - +
  • [7] The major birch pollen allergen Bet v 1 binds lipids from birch and grass pollen but not from peanuts
    Gepp, B.
    Ackerbauer, D.
    Lengger, N.
    Gruber, F.
    Mildner, M.
    Breiteneder, H.
    [J]. ALLERGY, 2014, 69 : 464 - 464
  • [8] The first plant allergen to be cloned-the story of the major birch pollen allergen Bet v 1
    Breiteneder, Heimo
    [J]. ALLERGY, 2024, 79 (04) : 1071 - 1072
  • [9] Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1
    Mahler, V
    Vrtala, S
    Kuss, O
    Diepgen, TL
    Suck, R
    Cromwell, O
    Fiebig, H
    Hartl, A
    Thalhamer, J
    Schuler, G
    Kraft, D
    Valenta, R
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (01): : 115 - 122
  • [10] The major birch allergen, Bet v 1, shows affinity for a broad spectrum of physiological ligands
    Mogensen, JE
    Wimmer, R
    Larsen, JN
    Spangfort, MD
    Otzen, DE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (26) : 23684 - 23692